[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

October 26, 2018
Comment & Response

Failure to Accurately Disclose Conflicts of Interest in Articles Published in JAMA Oncology

Abstract Full Text
free access
JAMA Oncol. Published online October 26, 2018. doi:10.1001/jamaoncol.2018.5674
Correction

Missing Conflict of Interest Disclosure

Abstract Full Text
free access
JAMA Oncol. Published online October 26, 2018. doi:10.1001/jamaoncol.2018.5678
October 25, 2018
Original Investigation

Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal CancerThe UNICANCER PRODIGE18 Randomized Clinical Trial

Abstract Full Text
JAMA Oncol. Published online October 25, 2018. doi:10.1001/jamaoncol.2018.4465

This open-label, randomized phase 2 trial evaluates progression-free survival with chemotherapy plus bevacizumab vs cetuximab among patients with progression of metastatic colorectal cancer (mCRC) after bevacizumab plus chemotherapy.

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab TherapyThree-Year Follow-up of a Randomized Phase 3 Trial

Abstract Full Text
JAMA Oncol. Published online October 25, 2018. doi:10.1001/jamaoncol.2018.4514

This follow-up of a randomized phase 3 trial compares the 3-year survival with nivolumab vs that with dacarbazine in patients with previously untreated BRAF wild-type advanced melanoma.

Viewpoint

Redefining the Role of Prophylactic Cranial Irradiation in the Modern Era of Active Surveillance in Small Cell Lung Cancer

Abstract Full Text
JAMA Oncol. Published online October 25, 2018. doi:10.1001/jamaoncol.2018.4833

This Viewpoint discusses the role of prophylactic cranial irradiation in small cell lung cancer in the current setting of active surveillance via magnetic resonance imaging.

Cancer Care Chronicles

Surviving Cancer in the Midst of a Treatment RevolutionHope and Delusion

Abstract Full Text
JAMA Oncol. Published online October 25, 2018. doi:10.1001/jamaoncol.2018.4430

In this article, the author discusses his struggles with hope and delusion in his personal experience with renal cell carcinoma.

Comment & Response

Pacritinib in Patients With Myelofibrosis

Abstract Full Text
JAMA Oncol. Published online October 25, 2018. doi:10.1001/jamaoncol.2018.4830

Pacritinib in Patients with Myelofibrosis—Reply

Abstract Full Text
JAMA Oncol. Published online October 25, 2018. doi:10.1001/jamaoncol.2018.4842
October 19, 2018
Original Investigation

Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-upA Phase 1b Clinical Trial

Abstract Full Text
JAMA Oncol. Published online October 19, 2018. doi:10.1001/jamaoncol.2018.5152

This phase 1b multicohort study assessed 33 patients with advanced triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel to examine its safety, tolerability, and preliminary clinical activity.

October 18, 2018
Original Investigation

Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.4292

This survey study of patients undergoing radiotherapy for cancer compares clinician advice against using topical agents before radiotherapy to avoid an increased radiation dose to the skin with the results of a dosimetric study and a preclinical study in an animal model.

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian CancerA Randomized Clinical Trial

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.3773

This phase 1 and 2 clinical trial examines progression-free survival in patients with ovarian or breast cancer treated with alisertib in combination with paclitaxel vs paclitaxel alone.

Research Letter

The Use of “Trend” Statements to Describe Statistically Nonsignificant Results in the Oncology Literature

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.4524

This study examines recent original research articles in leading oncology journals to evaluate the use of statements about the trend of a P value toward significance to describe statistically nonsignificant results.

Review

Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part SarcomaA Review

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.4490

This narrative review discusses current understanding of alveolar soft-part sarcomas with a focus on new findings and treatments.

Viewpoint

Decentered Crowdfunded Clinical Studies—Open a New Era of Medical Research

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.4650

This Viewpoint describes a process of conducting medical research that uses online crowdfunding as a model for recruiting and reviewing investigators and data.

Invited Commentary

Avoiding Topical Agents Before Daily RadiotherapyDebunking Dogma

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.4291
Comment & Response

Progestin, Not Progesterone

Abstract Full Text
JAMA Oncol. Published online October 18, 2018. doi:10.1001/jamaoncol.2018.4637
October 11, 2018
Original Investigation

Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women

Abstract Full Text
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4270

This prospective cohort study evaluates the 5-year risk of cervical precancer following p16/ki-67 dual-stain triage of HPV-positive women.

Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women

Abstract Full Text
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4280

This cohort study of women in the Nurses’ Health Study II assesses the association of obesity and weight gain since early adulthood with early-onset colorectal cancer.

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer

Abstract Full Text
free access
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4305

This study assesses whether plasma-based next-generation sequencing was associated with improved mutation detection and enhanced delivery of personalized therapy in a real-world clinical setting of patients with non–small cell lung cancer.

Viewpoint

Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors

Abstract Full Text
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4316

This Viewpoint assesses the current recommendation of treatment regimens with and without bleomycin for patients with metastatic germ cell tumors of the testis.

Editorial

Plasma vs Tissue Next-Generation Sequencing in Non–Small Cell Lung Cancer—Either, Both, or Neither?

Abstract Full Text
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4304
Comment & Response

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy

Abstract Full Text
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4625

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy—Reply

Abstract Full Text
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.4657
Correction

Incorrect Surnames in Byline

Abstract Full Text
free access
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.5229

Error In Figure 1

Abstract Full Text
free access
JAMA Oncol. Published online October 11, 2018. doi:10.1001/jamaoncol.2018.5346
October 4, 2018
Original Investigation

Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies

Abstract Full Text
has audio
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4149

This cohort study uses data from the Nurses’ Health Studies to evaluate associations between use of nonsteroidal anti-inflammatory drugs and risk of epithelial ovarian cancer.

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma

Abstract Full Text
has audio
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4154

This pooled analysis of the Nurses’ Health Study and the Health Professionals Follow-up Study examines the association between long-term use of aspirin and the development of hepatocellular carcinoma in adult men and women.

JAMA Oncology Clinical Challenge

Bilateral Lower Extremity Skin Eruptions in an HIV-Positive Man Receiving Pembrolizumab Monotherapy for Non–Small Cell Lung Cancer

Abstract Full Text
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4485

An HIV-positive man in his 30s being treated with pembrolizumab for metastatic programmed cell death ligand 1–positive squamous non–small cell lung cancer presents with pruritic, mildly painful, hyperpigmented papules and plaques on both feet. What is your diagnosis?

Viewpoint

How Pharmacy Benefit Managers Add to Financial ToxicityThe Copay Accumulator Program

Abstract Full Text
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4554

This Viewpoint examines the role of benefit managers and other mechanisms driving the sustained increases in prescription drug costs in the United States.

Editorial

Aspirin and Chemoprevention—Have We Arrived?

Abstract Full Text
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4138
Comment & Response

Cognitive Impairment Among Older Patients With Hematologic Cancers

Abstract Full Text
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4594

Cognitive Impairment Among Older Patients With Hematologic Cancers—Reply

Abstract Full Text
JAMA Oncol. Published online October 4, 2018. doi:10.1001/jamaoncol.2018.4654
×